Skip to content
GenoLensGenoLens

LTBP2

Chr 14q24.3

latent transforming growth factor beta binding protein 2

MANE:
ENST00000261978.9

Annotations refreshed 1 month ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • Corneal abnormalities

    BIALLELIC, autosomal or pseudoautosomal
  • Corneal dystrophy

    BIALLELIC, autosomal or pseudoautosomal
  • DDG2P

    BIALLELIC, autosomal or pseudoautosomal
  • Ehlers Danlos syndrome with a likely monogenic cause

    BIALLELIC, autosomal or pseudoautosomal
  • Glaucoma (developmental)

    BIALLELIC, autosomal or pseudoautosomal
  • Structural eye disease

    BIALLELIC, autosomal or pseudoautosomal
  • Bilateral congenital or childhood onset cataracts

    BIALLELIC, autosomal or pseudoautosomal
  • Fetal anomalies

    BIALLELIC, autosomal or pseudoautosomal

+4 more panels — install the extension to see the full list inline on any page.

Disease associations (Open Targets)

  • congenital glaucoma

    0.74
  • microspherophakia and/or megalocornea, with ectopia lentis and with or without secondary glaucoma

    0.72
  • glaucoma secondary to spherophakia/ectopia lentis and megalocornea

    0.66
  • Weill-Marchesani syndrome 3

    0.64
  • Microspherophakia

    0.60
  • open-angle glaucoma

    0.57
  • Weill-Marchesani syndrome

    0.51
  • glaucoma

    0.49
  • primary congenital glaucoma

    0.47
  • Juvenile glaucoma

    0.45

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Latent-transforming growth factor beta-binding protein 2

May play an integral structural role in elastic-fiber architectural organization and/or assembly

Curated MONDO disease pages that list LTBP2 among their top associated genes.

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.